Clinicopathological features of chronic inflammatory demyelinating polyradiculoneuropathy in childhood

Journal of the Neurological Sciences

Volumn 154, Issue 1, 1998, Pages 66-71

  Hattori, Naoki ^a   Ichimura, Miyuki ^a   Aoki, Shin Ichiro ^a   Nagamatsu, Masaaki ^a   Yasuda, Takeshi ^a   Kumazawa, Kazuhiko ^b   Yamamoto, Koji ^b   Terunori Mitsuma, ^b   Sobue, Gen ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Fourth Department of Internal Medicine   (Japan)

Author keywords

Childhood CIDP; Corticosteroid therapy; Subacute progression

Indexed keywords

CORTICOSTEROID;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DEMYELINATION; GUILLAIN BARRE SYNDROME; HUMAN; PRIORITY JOURNAL;

ADOLESCENT; ADRENAL CORTEX HORMONES; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DEMYELINATING DISEASES; ELECTROPHYSIOLOGY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYELIN SHEATH; NEURAL CONDUCTION; NEUROLOGIC EXAMINATION; POLYRADICULONEUROPATHY; SURAL NERVE; TREATMENT OUTCOME;

EID: 0032554038     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00216-5     Document Type: Article

References (28)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force, 1991 Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology. 41:1991;617-618.
2. Asbury A.K., Arnason B.G.W., Karp H.R., McFarlin D.E. Criteria for diagnosis of Guillain-Barré syndrome. Ann. Neurol. 3:1978;565-566.
3. Colan R.V., Snead III O.C., Oh S.J., Benton J.W. Steroid-responsive polyneuropathy with subacute onset in childhood. J. Paediatrics. 97:1980;374-377.
4. Cornblath D.R., Chaudhry V., Griffin J.W. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin. Ann. Neurol. 30:1991;104-106.
5. Dyck P.J., Lais A.C., Ohta M., Bastron J.A., Okazaki H., Groover R.V. Chronic inflammatory polyradiculoneuropathy. Mayo Clin. Proc. 50:1975;621-637.
6. Dyck P.J., O'Brien P.C., Oviatt K.F., Dinapoli R.P., Daube J.R., Bartleson J.D., Mokri B., Swift T., Low P.A., Windebank A.J. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann. Neurol. 11:1982;136-141.
7. Dyck P.J., Daube J., O'Brien P.C., Pineda A., Low P.A., Windebank A.J., Swanson C. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. New Engl. J. Med. 314:1986;461-465.
8. Dyck, P.J., Thomas, P.K., Griffin, J.W., Low, P.A., Poduslo, J.F., 1993. Chronic inflammatory demyelinating polyradiculoneuropathy. In: Sauders, W.B.(Ed.), Peripheral Neuropathy, Volume 2, pp. 1498-1517.
9. Ferriere G., Denef J.F., Rodriguez J., Guzzetta F. Morphometric studies of normal sural nerves in children. Muscle and Nerve. 8:1985;697-704.
10. Hahn A.F., Bolton C.F., Pillay N., Chalk C., Benstead T., Birl V., Shumak K., Vandervoort M.K., Feasby T.E. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy (CIDP). A double-blind, sham controlled, cross-over study. Brain. 119:1996;1055-1066.
11. Hahn A.F., Bolton C.F., Zochodne D., Feasby T.E. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study. Brain. 119:1996;1067-1077.
12. Hanemann C.O., Gabreëls-Festen A.A.W.M., Müller H.W., Stoll G. Low affinity NGF receptor expression in CMT1A nerve biopsies of different disease stages. Brain. 119:1996;1461-1469.
13. Hughes R., Sanders E., Hall S., Atkinson P., Colchester A., Payan P. Subacute idiopathic demyelinating polyradiculoneuropathy. Arch. Neurol. 49:1992;612-616.
14. Jakobs J.M., Love S. Qualitative and quantitative morphology of human sural nerve at different ages. Brain. 108:1985;897-924.
15. Kimura, J., 1989. Principles of nerve conduction studies. In: Davis, F.A. (Ed.), Electrodiagnosis in disease of nerve and muscle: principles and practice, Edition 2, pp. 78-102.
16. Kumazawa K., Sobue G., Yamamoto K., Kitano M., Nakamura S., Kato K., Mitsuma T. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy different beneficial effects and their correlation to the clinical features. Int. Med. 34:1995;537-541.
17. MaCombe P.A., Pollard J.D., Mcleod J.G. Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain. 110:1987;1617-1630.
18. Nemni, R., Amado, S., Fazio, R., Galardi, G., Preritali, S., Comi, G., Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating neuropathy not responsive to other treatments. J. Neurol. Neurosurg. Psychiatry.
19. Nevo Y., Pestronk A., Kornberg A.J., Connolly A.M., Yee W.C., Iqbal I., Shield L.K. Childhood chronic inflammatory demyelinating neuropathies: Clinical course and long-term follow-up. Neurology. 47:1996;98-102.
20. Oh S.J. Subacute demyelinating polyneuropathy responding to corticosteroid treatment. Arch. Neurol. 35:1978;509-516.
21. Prineas J.W., Mcleod J.G. J. Neurol. Sci. 27:1976;427-458.
22. Simmons Z., Albers J.W., Bromberg M.B., Feldman E.L. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 43:1993;2202-2209.
23. Sladky J.T., Brown M.J., Berman P.H. Chronic inflammatory demyelinating polyneuropathy of infancy: A corticosteroid-responsive disorder. Ann. Neurol. 20:1986;76-81.
24. Sobue G., Hashizume Y., Mukai E., Hirayama M., Mitsuma T., Takahashi A. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain. 112:1989;209-232.
25. van Doorn P.A., Brand A., Strengers P.F.W., Meulstee J. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double-blind, placebo-controlled crossover study. Neurology. 40:1990;209-212.
26. van Swieten J.C., Koudstaal P.J., Visser M.C., Schouten H.J.A., van Gijin J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 19:1988;604-607.
27. Vedanarayanan V.V., Kandt R.S., Lewis D.V., Delong G.R. Chronic inflammatory demyelinating polyradiculoneuropathy of childhood: Treatment with high-dose intravenous immunoglobulin. Neurology. 41:1991;828-830.
28. Vital A., Vital C., Brechenmacher C., Fontan D., Castaing Y. Chronic inflammatory demyelinating polyneuropathy in childhood: ultrastructural features of peripheral nerve biopsies in four cases. Eur. J. Paediatr. 149:1990;654-658.